Kerem Çebi

EvoDose Select is a research prototype that guesses who should pause prostate-cancer hormone therapy. Using real patients' blood-test histories, Meta Muse models guesses drug-sensitive and drug-resistant cells, simulates break plans, and predicts which patients would save the most time off the drug without losing control of the cancer.